199 related articles for article (PubMed ID: 21908708)
1. Restoring soluble guanylyl cyclase expression and function blocks the aggressive course of glioma.
Zhu H; Li JT; Zheng F; Martin E; Kots AY; Krumenacker JS; Choi BK; McCutcheon IE; Weisbrodt N; Bögler O; Murad F; Bian K
Mol Pharmacol; 2011 Dec; 80(6):1076-84. PubMed ID: 21908708
[TBL] [Abstract][Full Text] [Related]
2. Cytokine-induced S-nitrosylation of soluble guanylyl cyclase and expression of phosphodiesterase 1A contribute to dysfunction of longitudinal smooth muscle relaxation.
Rajagopal S; Nalli AD; Kumar DP; Bhattacharya S; Hu W; Mahavadi S; Grider JR; Murthy KS
J Pharmacol Exp Ther; 2015 Mar; 352(3):509-18. PubMed ID: 25550199
[TBL] [Abstract][Full Text] [Related]
3. Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation.
Mujoo K; Sharin VG; Martin E; Choi BK; Sloan C; Nikonoff LE; Kots AY; Murad F
Nitric Oxide; 2010 Jan; 22(1):43-50. PubMed ID: 19948239
[TBL] [Abstract][Full Text] [Related]
4. Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells.
El-Sehemy A; Chang AC; Azad AK; Gupta N; Xu Z; Steed H; Karsan A; Fu Y
Cell Signal; 2013 Dec; 25(12):2780-7. PubMed ID: 24041655
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension.
Schermuly RT; Stasch JP; Pullamsetti SS; Middendorff R; Müller D; Schlüter KD; Dingendorf A; Hackemack S; Kolosionek E; Kaulen C; Dumitrascu R; Weissmann N; Mittendorf J; Klepetko W; Seeger W; Ghofrani HA; Grimminger F
Eur Respir J; 2008 Oct; 32(4):881-91. PubMed ID: 18550612
[TBL] [Abstract][Full Text] [Related]
6. Nucleotidyl cyclase activity of particulate guanylyl cyclase A: comparison with particulate guanylyl cyclases E and F, soluble guanylyl cyclase and bacterial adenylyl cyclases CyaA and edema factor.
Beste KY; Spangler CM; Burhenne H; Koch KW; Shen Y; Tang WJ; Kaever V; Seifert R
PLoS One; 2013; 8(7):e70223. PubMed ID: 23922959
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle.
Hamad AM; Range S; Holland E; Knox AJ
Am J Physiol; 1997 Oct; 273(4):L807-13. PubMed ID: 9357856
[TBL] [Abstract][Full Text] [Related]
8. Ammonia affects the activity and expression of soluble and particulate GC in cultured rat astrocytes.
Konopacka A; Freśko I; Piaskowski S; Albrecht J; Zielińska M
Neurochem Int; 2006; 48(6-7):553-8. PubMed ID: 16517024
[TBL] [Abstract][Full Text] [Related]
9. High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria.
Wen JF; Cui X; Jin JY; Kim SM; Kim SZ; Kim SH; Lee HS; Cho KW
Circ Res; 2004 Apr; 94(7):936-43. PubMed ID: 14988225
[TBL] [Abstract][Full Text] [Related]
10. Role of sulfhydryl-dependent dimerization of soluble guanylyl cyclase in relaxation of porcine coronary artery to nitric oxide.
Zheng X; Ying L; Liu J; Dou D; He Q; Leung SW; Man RY; Vanhoutte PM; Gao Y
Cardiovasc Res; 2011 Jun; 90(3):565-72. PubMed ID: 21248051
[TBL] [Abstract][Full Text] [Related]
11. Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation.
Zhang G; Xiang B; Dong A; Skoda RC; Daugherty A; Smyth SS; Du X; Li Z
Blood; 2011 Sep; 118(13):3670-9. PubMed ID: 21803853
[TBL] [Abstract][Full Text] [Related]
12. Structure/activity relationships of (M)ANT- and TNP-nucleotides for inhibition of rat soluble guanylyl cyclase α1β1.
Dove S; Danker KY; Stasch JP; Kaever V; Seifert R
Mol Pharmacol; 2014 Apr; 85(4):598-607. PubMed ID: 24470063
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory phosphorylation of soluble guanylyl cyclase by muscarinic m2 receptors via Gbetagamma-dependent activation of c-Src kinase.
Murthy KS
J Pharmacol Exp Ther; 2008 Apr; 325(1):183-9. PubMed ID: 18180373
[TBL] [Abstract][Full Text] [Related]
14. Soluble guanylyl cyclase: more secrets revealed.
Pyriochou A; Papapetropoulos A
Cell Signal; 2005 Apr; 17(4):407-13. PubMed ID: 15601619
[TBL] [Abstract][Full Text] [Related]
15. Two autocrine pathways to regulate cyclic GMP synthesis in cultured human retinal pigment epithelial cells.
Diederen RM; La Heij EC; Markerink-van Ittersum M; Hendrikse F; de Vente J
Ophthalmic Res; 2008; 40(5):227-34. PubMed ID: 18437032
[TBL] [Abstract][Full Text] [Related]
16. An evolutionarily conserved mechanism for sensitization of soluble guanylyl cyclase reveals extensive nitric oxide-mediated upregulation of cyclic GMP in insect brain.
Ott SR; Delago A; Elphick MR
Eur J Neurosci; 2004 Sep; 20(5):1231-44. PubMed ID: 15341595
[TBL] [Abstract][Full Text] [Related]
17. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
[TBL] [Abstract][Full Text] [Related]
18. Alternative splicing impairs soluble guanylyl cyclase function in aortic aneurysm.
Martin E; Golunski E; Laing ST; Estrera AL; Sharina IG
Am J Physiol Heart Circ Physiol; 2014 Dec; 307(11):H1565-75. PubMed ID: 25239802
[TBL] [Abstract][Full Text] [Related]
19. Soluble guanylate cyclase: a potential therapeutic target for heart failure.
Gheorghiade M; Marti CN; Sabbah HN; Roessig L; Greene SJ; Böhm M; Burnett JC; Campia U; Cleland JG; Collins SP; Fonarow GC; Levy PD; Metra M; Pitt B; Ponikowski P; Sato N; Voors AA; Stasch JP; Butler J;
Heart Fail Rev; 2013 Mar; 18(2):123-34. PubMed ID: 22622468
[TBL] [Abstract][Full Text] [Related]
20. Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway.
Hwang TL; Hung HW; Kao SH; Teng CM; Wu CC; Cheng SJ
Mol Pharmacol; 2003 Dec; 64(6):1419-27. PubMed ID: 14645672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
